Allied Investment Advisors LLC Buys 11,570 Shares of Amrize Ltd $AMRZ

Allied Investment Advisors LLC raised its position in shares of Amrize Ltd (NYSE:AMRZ) by 5.9% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 207,648 shares of the company’s stock after purchasing an additional 11,570 shares during the quarter. Amrize makes up approximately 1.7% of Allied Investment Advisors LLC’s investment portfolio, making the stock its 27th largest holding. Allied Investment Advisors LLC’s holdings in Amrize were worth $11,230,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in AMRZ. State of Wyoming bought a new position in shares of Amrize during the 3rd quarter worth approximately $32,000. Laurel Wealth Advisors LLC acquired a new stake in shares of Amrize during the 4th quarter worth approximately $34,000. US Bancorp DE bought a new stake in shares of Amrize in the 3rd quarter valued at $38,000. Costello Asset Management INC acquired a new position in shares of Amrize during the 3rd quarter valued at $44,000. Finally, Jones Financial Companies Lllp acquired a new position in shares of Amrize during the 3rd quarter valued at $53,000.

Insider Activity

In other Amrize news, CEO Jan Philipp Jenisch purchased 3,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 19th. The shares were acquired at an average cost of $49.96 per share, for a total transaction of $149,880.00. Following the completion of the acquisition, the chief executive officer owned 515,000 shares of the company’s stock, valued at $25,729,400. The trade was a 0.59% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Mario Gross bought 1,200 shares of the stock in a transaction dated Wednesday, May 20th. The shares were acquired at an average price of $48.63 per share, for a total transaction of $58,356.00. Following the completion of the purchase, the insider directly owned 34,747 shares in the company, valued at approximately $1,689,746.61. This trade represents a 3.58% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders bought a total of 129,554 shares of company stock worth $7,051,569 over the last quarter. Insiders own 0.54% of the company’s stock.

Amrize Trading Up 0.0%

AMRZ opened at $49.96 on Tuesday. Amrize Ltd has a fifty-two week low of $44.12 and a fifty-two week high of $65.94. The firm has a market capitalization of $27.63 billion and a PE ratio of 23.91. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.40 and a quick ratio of 0.89. The company’s 50-day moving average is $54.66 and its 200 day moving average is $55.10.

Amrize (NYSE:AMRZ) last released its quarterly earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). The company had revenue of $2.18 billion for the quarter. Amrize had a net margin of 9.70% and a return on equity of 9.84%. Amrize’s quarterly revenue was up 4.7% on a year-over-year basis. As a group, research analysts predict that Amrize Ltd will post 2.76 earnings per share for the current fiscal year.

Amrize Cuts Dividend

The company also recently announced a dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were issued a $0.11 dividend. The ex-dividend date was Tuesday, May 12th. Amrize’s dividend payout ratio is currently 21.05%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the stock. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Amrize in a report on Monday, February 23rd. Weiss Ratings lowered shares of Amrize from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, May 18th. Wall Street Zen raised shares of Amrize from a “sell” rating to a “hold” rating in a research report on Sunday, March 1st. Oppenheimer set a $68.00 target price on Amrize in a research report on Friday, May 1st. Finally, JPMorgan Chase & Co. raised their price objective on Amrize from $60.00 to $70.00 and gave the company an “overweight” rating in a research note on Thursday, March 5th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, Amrize presently has a consensus rating of “Moderate Buy” and a consensus price target of $64.86.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.